Workflow
心脉医疗(688016.SH)累计回购122.87万股 耗资1.29亿元
EndovastecEndovastec(SH:688016) 智通财经网·2025-09-02 08:10

Summary of Key Points Core Viewpoint - Xinmai Medical (688016.SH) announced a share repurchase program, indicating a commitment to enhancing shareholder value through buybacks [1] Company Actions - As of August 31, 2025, the company has repurchased a total of 1.2287 million shares through the Shanghai Stock Exchange trading system [1] - The highest price paid for the repurchased shares was 120.00 RMB per share, while the lowest price was 84.26 RMB per share [1] - The total amount spent on the share repurchase was 129 million RMB, excluding transaction fees such as stamp duty and commissions [1]